Ganglioside GT1b increases hyaluronic acid synthase 2 via PI3K activation with TLR2 dependence in orbital fibroblasts from thyroid eye disease patients

키워드

참고문헌 (38)

1. Kazim M, "Insights into the pathogenesis of thyroid-associated orbitopathy : evolving rationale for therapy", Arch Ophthalmol, 120, pp.380~386 (2002)
2. Garrity JA, "Pathogenesis of graves ophthalmopathy : implications for prediction, prevention, and treatment", Am J Ophthalmol, 142, pp.147~153 (2006)
3. Naik VM, "Immunopathogenesis of thyroid eye disease : emerging paradigms", Surv Ophthalmol, 55, pp.215~226 (2010)
4. Bahn RS, "Graves’ ophthalmopathy", N Engl J Med, 362, pp.726~738 (2010)
5. Smith TJ, "Connective tissue, glycosaminoglycans, and diseases of the thyroid", Endocr Rev, 10, pp.366~391 (1989)
6. Schulz T, "Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP", J Biol Chem, 282, pp.20999~21004 (2007)
7. Hansen C, "Increased sulfatation of orbital glycosaminoglycans in Graves’ ophthalmopathy", J Clin Endocrinol Metab, 84, pp.1409~1413 (1999)
8. Korducki JM, "Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts", Invest Ophthalmol Vis Sci, 33, pp.2037~2042 (1992)
9. Wong YK, "Stimulation of hyaluronan synthesis by interleukin-1beta involves activation of protein kinase C betaII in fibroblasts from patients with Graves’ ophthalmopathy", J Cell Biochem, 82, pp.58~67 (2001)
10. Wang HS, "TGF-beta induced hyaluronan synthesis in orbital fibroblasts involves protein kinase C betaII activation in vitro", J Cell Biochem, 95, pp.256~267 (2005)
11. Svennerholm L, "The Gangliosides", J Lipid Res, 5, pp.145~155 (1964)
12. Nakamura K, "A novel ganglioside in dogfish brain. Occurrence of a trisialoganglioside with a sialic acid linked to N-acetylgalactosamine", J Biol Chem, 263, pp.9896~9900 (1988)
13. Yu RK, "Structures, biosynthesis, and functions of gangliosides--an overview", J Oleo Sci, 60, pp.537~544 (2011)
14. Huwiler A, "Physiology and pathophysiology of sphingolipid metabolism and signaling", Biochim Biophys Acta, 1485, pp.63~99 (2000)
15. Kook KH, "Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid", Invest Ophthalmol Vis Sci, 52, pp.264~273 (2011)
16. Cantley LC, "The phosphoinositide 3-kinase pathway", Science, 296, pp.1655~1657 (2002)
17. 윤희정, "Contribution of TLR2 to the Initiation of Ganglioside-triggered Inflammatory Signaling", Molecules and Cells, 25(1), pp.99~104 (2008), 한국분자세포생물학회
18. Liu YD, "Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K", Akt and NF-kappaB signaling pathways, 2018, pp.59, 375~383
19. Lim ST, "Exogenous gangliosides increase the release of brain-derived neurotrophic factor", Neuropharmacology, 60, pp.1160~1167 (2011)
20. Kanda N, "Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells", Immunology, 96, pp.628~633 (1999)
21. Kanda N, "Gangliosides GD1b, GT1b, and GQ1b enhance IL-2 and IFN-gamma production and suppress IL-4 and IL-5 production in phytohemagglutininstimulated human T cells", J Immunol, 166, pp.72~80 (2001)
22. Hsieh AC, "Oncogenic AKTivation of translation as a therapeutic target", Br J Cancer, 105, pp.329~336 (2011)
23. Juric D, "Phase I dose-escalation study of taselisib, an oral pi3k inhibitor, in patients with advanced solid tumors", Cancer Discov, 7, pp.704~715 (2017)
24. Dreyling M, "Phosphatidylinositol 3-Kinase Inhibition by copanlisib in relapsed or refractory indolent lymphoma", J Clin Oncol, 35, pp.3898~3905 (2017)
25. Raphael J, "Phosphoinositide 3-kinase inhibitors in advanced breast cancer : A systematic review and meta-analysis", Eur J Cancer, 91, pp.38~46 (2018)
26. Xu J, "Protein kinase B", AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation, 2004, pp.279, 35914~35922
27. Zhang L, "Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves’ orbitopathy", J Clin Endocrinol Metab, 97, pp.653~662 (2012)
28. Kumar S, "A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves’ ophthalmopathy", J Mol Endocrinol, 46, pp.155~163 (2011)
29. Li B, "PI3K", AKT pathway mediates induction of IL-1RA by TSH in fibrocytes : modulation by PTEN, 2014, pp.99, 3363~3372
30. Thaiss CA, "Integration of Innate Immune Signaling", Trends Immunol, 37, pp.84~101 (2016)
31. Kawasaki T, "Toll-like receptor signaling pathways", Front Immunol, 5, pp.461~ (2014)
32. Lim HS, "Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy", Invest Ophthalmol Vis Sci, 55, pp.7441~7450 (2014)
33. Kaback LA, "Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts : potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy", J Clin Endocrinol Metab, 84, pp.4079~4084 (1999)
34. Zhang L, "Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts : contributory role in hyaluronan accumulation in thyroid dysfunction", J Biol Chem, 284, pp.26447~26455 (2009)
35. Pasonen-Seppanen S, "Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFRPI3K-AKT and p38 signaling", Histochem Cell Biol, 138, pp.895~911 (2012)
36. Qin J, "Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of hyaluronan synthase 2 through decreased ceramide production and activation of Akt", J Biol Chem, 287, pp.13620~13632 (2012)
37. Kultti A, "Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt", J Biol Chem, 285, pp.22901~22910 (2010)
38. Manning BD, "AKT", PKB signaling : navigating downstream, 2007, pp.129, 1261~1274

관련 논문AI추천